Chronic Disease

DMARDs for rheumatoid arthritis linked to lower dementia risk

April 12, 2024 - Research published in Rheumatic & Musculoskeletal Disease found that patients with rheumatoid arthritis (RA) who were taking biological disease-modifying antirheumatic drugs (DMARDs) had a 24% lower risk of dementia. Previous studies have linked RA with an elevated risk of dementia, identifying chronic systemic inflammation and dysregulation of...

Read More


More Articles

Comparing inflammatory bowel disease treatment options

by Veronica Salib

Last month, AbbVie sponsored several presentations and posters at the European Crohn's and Colitis Organization’s (ECCO) annual congress. Among these abstracts was the SEQUENCE study, which compared risankizumab and ustekinumab...

GLP-1 Medication Use Is Linked with Lower Anxiety, Depression Rates

by Veronica Salib

On Tuesday, February 6, 2024, Epic Research published the results of a dual-team Cosmos study, highlighting that taking certain glucagon-like peptide-1 (GLP-1) receptor agonists may reduce the chances...

Understanding the Pharmacotherapy of Hypertensive Disorders

by Veronica Salib

Hypertension is defined as a chronic condition characterized by high blood pressure. In an earlier publication, LifeSciencesIntelligence explored the different kinds of hypertensive disorders, their causes, and management. In this article,...

Researcher Study Non-Opioid Pain Medication for Diabetic Neuropathy

by Veronica Salib

On the tail of their win as the first FDA-approved CRISPR-based gene editing therapy, Vertex Pharmaceuticals announced the results of a phase 2 clinical trial for VX-548, a non-opioid pain management...

FDA Approves New Pediatric Medication for Type 2 Diabetes

by Veronica Salib

Adding to the arsenal of tools providers have to manage type 2 diabetes (T2D), the FDA has approved a new pediatric medication for managing the condition. The approval of Jardiance and Synjardy to...

Research Reveals That Forever Chemicals May Be Linked to Weight Gain

by Veronica Salib

Earlier this month, a study published in Obesity identified a link between weight gain and perfluorinated alkylate substances (PFAS), also known as forever chemicals, independent of dietary habits....

Sanofi Acquires Provention Bio for $2.9 Billion

by Hayden Schmidt

On Monday, the European healthcare company Sanofi announced a $2.9 billion acquisition deal with US-based Provention Bio. Under the terms of the agreement, Sanofi will pay $25 per share in cash,...

Understanding Multiple Sclerosis and the Role of Specialty Care

by Alivia Kaylor

Multiple sclerosis is an immune-mediated disease that affects nearly 1 million people in the United States and over 2.8 million worldwide. Given the complexity of treatment, specialty care teams play a vital role in disease management by...

RSV, How Pharmacists Can Help Patients Prevent and Manage Infections

by Alivia Kaylor

As respiratory syncytial virus (RSV), influenza (flu), and COVID-19 cases surge across the United States, pharmacists are encouraged to use their advanced healthcare role to educate patients and caregivers about preventing the transmission...

AstraZeneca Purchases CinCor Pharma Inc. in $1.8 Billion Acquisition

by Hayden Schmidt

This week, AstraZeneca announced its acquisition of Massachusetts-based CinCor Pharma as part of a transaction worth $1.8 billion. CinCor will support AstraZeneca’s mission to accelerate...

Respiratory Medications, Understanding Options, and Indications

by Veronica Salib

Over the past couple of years, healthcare industry members have had to become fast experts on treating respiratory diseases. With the progression of the COVID-19 pandemic and the lingering pulmonary effects associated with infection,...

Achieving Adequate Pain Management, Pharmacological Indications

by Veronica Salib

Data from the CDC suggests that, as of 2018, approximately 20.4% of adults in the United States were living with chronic pain. Additionally, 8% of US adults had high-impact chronic pain. Pain management is essential in healthcare, as...

Disease-Modifying Antirheumatic Drugs Effectively Treat Arthritis

by Veronica Salib

Arthritis, a chronic condition characterized by inflammation, is a common disease in the United States. Approximately 43.5% of people in the US living with arthritis experience some sort of limitation due to their condition. To manage...

Anticipating the 2023 Biosimilar Boom

by Veronica Salib

A recent analysis by Vantage Market Research found that in 2021 the global biosimilars market was valued at $28.46 billion. Projections based on market trajectory predict that the market will surpass $103.94 billion by 2028. While...

FDA Recommends New Asthma Rescue Treatment

by Veronica Salib

AstraZeneca and Avillion recently teamed up to develop PT027, an asthma rescue inhaler. PT027 is a pressurized metered-dose inhaler that delivers a fixed dose of two combined asthma medications,...

Study Finds Increased Prevalence of Nonpharmacological Pain Treatment

by Veronica Salib

Following a publication earlier this year that analyzed patterns in prescribing nonopioid pain medication, JAMA Network Open published an article on November 7, 2022, which compared trends in...

How Mesenchymal Stem Cells May Reduce the Need for Antirejection Drugs

by Veronica Salib

In a recent press release, Cynata Therapeutics, a biotechnology company, announced a partnership with Leiden University Medical Center (LUMC) to explore how mesenchymal stem cells may reduce the need...

Nearly 13% of Oral Anticancer Prescriptions Are Not Received

by Veronica Salib

The financial burden associated with cancer treatment and recovery is significant. Many patients struggle to obtain medicines and continued care. According to a recent study published in JAMA Network...

Novartis Is Losing Its Battle Against a Generic Drug for MS

by Hayden Schmidt

On Thursday of last week, the US Supreme Court (SCOTUS) allowed the launch of generic versions of Novartis’s Gilenya, siding with China’s HEC Pharm Co and other pharmaceutical companies...

Recent Articles